AMGN compared with CRSP: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CRSPCRISPR Therapeutics AG

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CRSPCRISPR Therapeutics AG

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

Q3 FY25±3.7%▲+7.81%×2.11

CRSP

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±7.8%▲+7.06%×0.91

Q1 FY26±5.9%▼−2.24%×0.37

= impliedAMGN realized, solidCRSP realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

Feb 13 '26

±3.6%

▲+8.46%

×2.36

Q3 FY25±8.4%▼−0.98%×0.12

AMGNAmgen Inc

466.31▲+1.21%· post 466.40

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

CRSPCRISPR Therapeutics AG

51.38▼−5.31%· post 51.38

ClosedOct 30 '26

Mkt cap$5.0BRevenue$10MQ2 FY26Revenue$4MFY25

Compare

ClosedOct 30 '26

AMGNAmgen Inc

CRSPCRISPR Therapeutics AG

466.31▲+1.21%post 466.40

Price

51.38▼−5.31%post 51.38

$251.9B

Mkt cap

$5.0B

Q2 FY26$10.1B

Revenue

$10MQ2 FY26

FY25$36.8B

Revenue

$4MFY25

AMGN466.31▲+1.21%vsCRSP51.38▼−5.31%ClosedOct 30 '26